SciClone Announces Resignation Of Trevor Jones From Board

Sciclone Pharmaceuticals Q4 12 Earnings Conference Call At 4:30 PM ET

SciClone Pharma Names Hong Zhao CEO China Operations - Quick Facts

Trade SCLN now with

4/6/2012 1:11 PM ET

SciClone Pharmaceuticals Inc. (SCLN: Quote) announced the resignation of Trevor Jones from the company's Board of Directors. Prof. Jones has been a member of the SciClone Board since 2009.

SciClone also announced the resignation of Israel Rios as of April 6. The company said Rios departure was related to winding down of its U.S.-based product development programs.

Click here to receive FREE breaking news email alerts for Sciclone Pharmaceuticals Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 131 Articles

Editors Pick

Gap Profit Climbs 43%

Gap Inc. Thursday after the markets closed that its first quarter profit rose 43% from last year, helped by higher sales and improved margins. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly sales. At the same time, the company eaffirmed its fiscal year 2013 earnings outlook, which is below analysts' current consensus estimate.

Stocks Close Modestly Lower But Well Off Worst Levels - U.S. Commentary

After moving sharply lower at the start of trading on Thursday, stocks showed a substantial recovery attempt over the course of the trading day. The rebound came as upbeat housing data helped offset worries about the Federal Reserve. The major averages climbed well off their worst levels of the day but still ended the session in the red.

Obama Outlines Counterterrorism Policy To Confront Shifting Threats

President Barack Obama delivered a highly-anticipated speech on his administration's evolving counterterrorism policies on Thursday, suggesting that the U.S. needs to move away from a "boundless global war on terror." More than a decade after the 9/11 attacks, Obama argued that the terrorist threat has shifted and evolved.